Clinical Outcomes With Ring Sideroblasts and SF3B1 Mutations in Myelodysplastic Syndromes: MDS Clinical Research Consortium Analysis

Clinical Lymphoma, Myeloma and Leukemia - Tập 18 - Trang 528-532 - 2018
Yazan Migdady1, John Barnard2, Najla Al Ali1, David P. Steensma3, Amy DeZern4, Gail Roboz5, Guillermo Garcia-Manero6, Mikkael A. Sekeres2, Rami S. Komrokji1
1Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
2Department of Leukemia, Cleveland Clinic, Cleveland, OH
3Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
4Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD
5Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medical, New York, NY
6Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Tài liệu tham khảo

Thông tin
Thông tin xuất bản

Clinical Lymphoma, Myeloma and Leukemia

Tập 18

528-532

Thông tin tác giả